Ticker Details
Beam Therapeutics Inc.
IPO Date:	February 6, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.8B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.49 | 3.44%
Avg Daily Range (30 D):	$1.06 | 3.54%
Avg Daily Range (90 D):	$0.87 | 3.23%

Institutional Daily Volume
Avg Daily Volume:	1.01M
Avg Daily Volume (30 D):	1.62M
Avg Daily Volume (90 D):	1.7M

Trade Size
Avg Trade Size (Sh.):	59
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	3,362
Avg Institutional Trade:	$3.16M
Avg Institutional Trade (30 D):	$3.38M
Avg Institutional Trade (90 D):	$3.35M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.91M
Avg Closing Trade (30 D):	$5.43M
Avg Closing Trade (90 D):	$5.43M
Avg Closing Volume:	142.7K

News

Feb 24, 2026 @ 1:00 PM Kyverna Therapeutics Appoints Biotech Leaders Srav... Source: Na

Feb 24, 2026 @ 12:00 PM Beam Therapeutics Announces $500 Million Strategic... Source: Na

Feb 23, 2026 @ 9:00 PM Beam Therapeutics to Host Investor Webcast for Fou... Source: Na

Dec 6, 2025 @ 1:00 PM Beam Therapeutics Reports Updated Data from BEACON... Source: Beam Therapeutics

Jun 28, 2025 @ 1:10 PM 10 Under-the-Radar Healthcare Stocks With Incredib... Source: Dan Victor

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-4.41	$-1.1	$-1
Diluted EPS	$-4.41	$-1.1	$-1
Revenue	$55.7M	$9.7M	$8.47M
Gross Profit
Net Income / Loss	$-414.64M	$-112.73M	$-102.29M
Operating Income / Loss	$-466.29M	$-126.81M	$-120.15M
Cost of Revenue
Net Cash Flow	$37.86M	$-14.15M	$-245.75M
PE Ratio